We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Effectiveness of BNT162b2 XBB Vaccine Against XBB and JN.1 Sublineages.
- Authors
Tartof, Sara Y; Slezak, Jeff M; Puzniak, Laura; Frankland, Timothy B; Ackerson, Bradley K; Jodar, Luis; McLaughlin, John M
- Abstract
We provide updated results (11 October 2023 through 29 February 2024) from our previously conducted test-negative case-control study in Kaiser Permanente Southern California to evaluate sublineage-specific effectiveness of the BNT162b2 XBB1.5-adapted vaccine. Results suggest that XBB1.5-adapted vaccines may have reduced effectiveness against JN.1 versus XBB sublineages.
- Subjects
SARS-CoV-2 Omicron variant; VACCINE effectiveness; COVID-19 vaccines; COVID-19; CASE-control method
- Publication
Open Forum Infectious Diseases, 2024, Vol 11, Issue 7, p1
- ISSN
2328-8957
- Publication type
Article
- DOI
10.1093/ofid/ofae370